SlideShare une entreprise Scribd logo
1  sur  19
IRRITABLE BOWEL SYNDROME 
RAGHAV GARG 
MBBS 2011
WHAT IS IRRITABLE BOWEL SYNDROME 
 irritable bowel syndrome can be defined 
,as an idiopathic clinical entity characterized by 
chronic(more than 3months)abdominal pain or discomfort 
that occurs in association with altered bowel habits 
 Most are due to disorders of intestinal motility.
SYMPTOMS 
These symptoms may be continuous or intermittent. 
Consensus definition of irritable bowel syndrome is 
abdominal discomfort or pain that has two of the 
following three features; 
1.Relieved with defecation. 
2.Onset associated with a change in frequency 
of stool 
3.onset associated with a change in form of 
stool 
.
 Other symptoms supporting the diagnosis include 
 abnormal stool frequency; 
 abnormal stool form (lumpy or hard;loose or watery); 
 abnormal stool passage (straining, urgency,or feeling of 
abdominal distention
Signs 
 Examination often unremarkable 
 Generalized abdominal tenderness
PATHO -PHYSIOLOGY OF IBS 
SUGGETSED THEORIES 
1.Altered responses of general stress circuits. 
2.The alternation of autonomic and 
neuroendocrine systems in response to visceral 
stimulation. 
3. Serotonin release 
4.low grade inflammation 
5. IBS secondary to GIT 
infections
6.Increased lactobacilli, coliform in IBS 
7. Genetic factors
TREATMENT
Constipation 
1.bulk purgatives Ispaghulla and pysllium 
Methyl cellulose 
2. Anthraquinones tegaserod 
Diarrhoea 
1.Bulking agent 
2.Antisecretory Sulfasalazine 
Mesalazine
TREATMENT 
 FOOD INTOLERANCE  TRY EXCLUSION DIET 
 CONSTIPATION 
1. INCREASE FIBER UPTAKE 
2. BULK PURGATIVES 
 ISPAGHULA AND PSYLLIUM 
 NATURAL COLLOIDAL MUCILAGE FORMS GELATINOUS MASS 
BY ABSORBING WATER 
 3-12 g OF HUSK IS MIXED WITH WATER OR MILK 
 TAKEN DAILY ACT IN 1- 3 DAYS
 METHYLCELLULOSE 
 SEMISYNTHETIC COLLOIDAL HYDROPHILIC DERIVATIVE OF 
CELLULOSE 
 4-6 g/day 
 They have non fermentable fiber better than lactulose which ferments 
3 .ANTHRAQUINONES 
 TEGASEROD 
 NEW SELECTIVE 5 – HT4 RECEPTOR PARTIAL AGONIST WITH NO 
ACTION ON OTHER RECEPTORS 
 IT ENHANCES RELEASE OF Ach AND calcitonin GENE RELATED 
PEPTIDE WHICH PROMOTE PERISTALTIC REFLEX AND COLONIC 
SECRETION 
 elimination t1/2 of absorbed drug 11 hr
 STIMULANT PURGATIVES 
(PHENOLPHTHALEIN AND BISACODYL) 
ARE CONTRAINDICATED
 DIARRHOEA 
1. Bulking agent 
as absorbants ispaghula and other bulk forming colloid are 
useful in both constipation and diarrhoea . 
They modify the consistency and frequency of stools by 
absorbing water
 ANTISECRETORY 
SULFASALAZINE 
 compound of 5-aminosalicylic acid with sulfapyridine linked 
through azo bond. 
 5-ASA  it inhibits COX and LOX ,decreased PG and LT, they play 
minor role in the therapeutic effect. 
 Inhibition of cytokine, PAF, TNF and nuclear transcription factor 
 Migration of inflammatory cells into bowel wall is interfered and 
mucosal secretion is reduced
 DOSE -3-4 g/day induces remission over a few 
weeks but relapses are common after stoppage 
 Maintenance therapy with 1.5-2 g/day postpone 
relapse 
 Adverse effects 
 Rashes ,fever, joint pain, hemolysis
 MESALAZINE 
 formulated as delayed release preparation by 
coating of 5-ASA with acrylic polymer 
 This helps in effective delivery of the drug 
 DOSE - 2.4 gm prevents relapses 
 adverse effects are less than sulfasalazine
 OTHER FORMS – 5 ASA enemas 
 Olsalazine 
 Balsalazine 
 Other drugs helpful 
 Corticosteroids 
 Immunosuppressants 
 Antispasmodic  in colic and bloating
Antimotility drug 
 (opoid drugs  codiene , diphenoxylate , loperamide ) 
 Contraindicated as they increase the intraluminal pressure
THANK YOU

Contenu connexe

Tendances

Irritable bowel syndrome
Irritable bowel syndromeIrritable bowel syndrome
Irritable bowel syndrome
Reem N. Jallad
 
Irritable bowel syndrome disease
Irritable bowel syndrome disease Irritable bowel syndrome disease
Irritable bowel syndrome disease
mrbahia
 

Tendances (20)

IBS
IBSIBS
IBS
 
Irritable bowel syndrome (ibs)
Irritable bowel syndrome (ibs)Irritable bowel syndrome (ibs)
Irritable bowel syndrome (ibs)
 
Irritable bowel syndrome
Irritable bowel syndromeIrritable bowel syndrome
Irritable bowel syndrome
 
Constipation
ConstipationConstipation
Constipation
 
IBS Presentation
IBS PresentationIBS Presentation
IBS Presentation
 
Irritable bowel syndrome
Irritable bowel syndromeIrritable bowel syndrome
Irritable bowel syndrome
 
Irritable bowel syndrome disease
Irritable bowel syndrome disease Irritable bowel syndrome disease
Irritable bowel syndrome disease
 
Irritable bowel syndrome
Irritable bowel syndromeIrritable bowel syndrome
Irritable bowel syndrome
 
Irritable bowel syndrome
Irritable bowel syndromeIrritable bowel syndrome
Irritable bowel syndrome
 
Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Irritable Bowel Syndrome: An Update in Pathophysiology and Management Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Irritable Bowel Syndrome: An Update in Pathophysiology and Management
 
Irritable Bowel Syndrome (IBS)
Irritable Bowel Syndrome (IBS)Irritable Bowel Syndrome (IBS)
Irritable Bowel Syndrome (IBS)
 
Inflamatory bowel disease, IBD
Inflamatory bowel disease, IBDInflamatory bowel disease, IBD
Inflamatory bowel disease, IBD
 
Constipation
ConstipationConstipation
Constipation
 
Irritable bowel syndrome - diagnosis, pathophysiology and pharmacology
Irritable bowel syndrome - diagnosis, pathophysiology and pharmacologyIrritable bowel syndrome - diagnosis, pathophysiology and pharmacology
Irritable bowel syndrome - diagnosis, pathophysiology and pharmacology
 
Ulcerative Colitis (UC)
Ulcerative Colitis (UC) Ulcerative Colitis (UC)
Ulcerative Colitis (UC)
 
Peptic ulcer
Peptic ulcerPeptic ulcer
Peptic ulcer
 
Approach to constipation
Approach to constipationApproach to constipation
Approach to constipation
 
IBS, Constipation & Diarrhea
IBS, Constipation & DiarrheaIBS, Constipation & Diarrhea
IBS, Constipation & Diarrhea
 
Ulcerative colitis
Ulcerative colitisUlcerative colitis
Ulcerative colitis
 
Constipation
ConstipationConstipation
Constipation
 

En vedette

Irritable Bowel Syndrome Haitham Ahmed
Irritable Bowel Syndrome   Haitham AhmedIrritable Bowel Syndrome   Haitham Ahmed
Irritable Bowel Syndrome Haitham Ahmed
MedicineAndHealthUSA
 

En vedette (19)

Ibs
IbsIbs
Ibs
 
GIT 4th IBS 2017
GIT 4th IBS 2017GIT 4th IBS 2017
GIT 4th IBS 2017
 
Industrialised building system (IBS)
Industrialised building system (IBS)Industrialised building system (IBS)
Industrialised building system (IBS)
 
Aum profile
Aum profileAum profile
Aum profile
 
GIT j club ibs board case.
GIT j club ibs board case.GIT j club ibs board case.
GIT j club ibs board case.
 
Part2
Part2Part2
Part2
 
Skin(Integumentary System)
Skin(Integumentary System)Skin(Integumentary System)
Skin(Integumentary System)
 
Part1
Part1Part1
Part1
 
Irritable bowel syndrome - interpreting a diagnosis
Irritable bowel syndrome - interpreting a diagnosisIrritable bowel syndrome - interpreting a diagnosis
Irritable bowel syndrome - interpreting a diagnosis
 
Part4
Part4Part4
Part4
 
Part3
Part3Part3
Part3
 
Chapt19 Apr Lecture
Chapt19 Apr LectureChapt19 Apr Lecture
Chapt19 Apr Lecture
 
Medicine 5th year, 8th lecture (Dr. Mohammad Shaikhani)
Medicine 5th year, 8th lecture (Dr. Mohammad Shaikhani)Medicine 5th year, 8th lecture (Dr. Mohammad Shaikhani)
Medicine 5th year, 8th lecture (Dr. Mohammad Shaikhani)
 
Heather's IBS Diet Cheat Sheet
Heather's IBS Diet Cheat SheetHeather's IBS Diet Cheat Sheet
Heather's IBS Diet Cheat Sheet
 
What is Irritable Bowel Syndrome?
What is Irritable Bowel Syndrome?What is Irritable Bowel Syndrome?
What is Irritable Bowel Syndrome?
 
Dr Vivek Baliga - The Basics Of Medical Statistics
Dr Vivek Baliga - The Basics Of Medical StatisticsDr Vivek Baliga - The Basics Of Medical Statistics
Dr Vivek Baliga - The Basics Of Medical Statistics
 
ECG In Ischemic Heart Disease - Dr Vivek Baliga Review
ECG In Ischemic Heart Disease - Dr Vivek Baliga ReviewECG In Ischemic Heart Disease - Dr Vivek Baliga Review
ECG In Ischemic Heart Disease - Dr Vivek Baliga Review
 
Irritable Bowel Syndrome Haitham Ahmed
Irritable Bowel Syndrome   Haitham AhmedIrritable Bowel Syndrome   Haitham Ahmed
Irritable Bowel Syndrome Haitham Ahmed
 
GIT irritable bowel syndrome (IBS) for 5th year 2011
GIT irritable bowel syndrome (IBS) for 5th year 2011GIT irritable bowel syndrome (IBS) for 5th year 2011
GIT irritable bowel syndrome (IBS) for 5th year 2011
 

Similaire à Ibs

Laxative and antidiarrheal agents
Laxative and antidiarrheal agentsLaxative and antidiarrheal agents
Laxative and antidiarrheal agents
Rahul B S
 
Class anti diarrheals
Class anti diarrhealsClass anti diarrheals
Class anti diarrheals
Raghu Prasada
 
Non steroidal anti inflammatory drugs
Non steroidal anti inflammatory drugsNon steroidal anti inflammatory drugs
Non steroidal anti inflammatory drugs
Nimra Iqbal
 

Similaire à Ibs (20)

Functional dyspepsia-Approach
Functional dyspepsia-ApproachFunctional dyspepsia-Approach
Functional dyspepsia-Approach
 
Antiemetics, Anti-Diarrheals and Drugs for Constipation and irritable bowel s...
Antiemetics, Anti-Diarrheals and Drugs for Constipation and irritable bowel s...Antiemetics, Anti-Diarrheals and Drugs for Constipation and irritable bowel s...
Antiemetics, Anti-Diarrheals and Drugs for Constipation and irritable bowel s...
 
Gastroesophageal reflux disease
Gastroesophageal reflux diseaseGastroesophageal reflux disease
Gastroesophageal reflux disease
 
Drugs used in the treatment of irritable bowel syndrome (IBS)
Drugs used in the treatment of irritable bowel syndrome (IBS)Drugs used in the treatment of irritable bowel syndrome (IBS)
Drugs used in the treatment of irritable bowel syndrome (IBS)
 
Laxative and antidiarrheal agents
Laxative and antidiarrheal agentsLaxative and antidiarrheal agents
Laxative and antidiarrheal agents
 
INFLAMMATORY BOWEL DISEASE IBD
INFLAMMATORY BOWEL DISEASE IBDINFLAMMATORY BOWEL DISEASE IBD
INFLAMMATORY BOWEL DISEASE IBD
 
Class anti diarrheals
Class anti diarrhealsClass anti diarrheals
Class anti diarrheals
 
Racecadotril
RacecadotrilRacecadotril
Racecadotril
 
Diarrhoea
DiarrhoeaDiarrhoea
Diarrhoea
 
Gastroesophageal Reflux Disease in Children
Gastroesophageal Reflux Disease in ChildrenGastroesophageal Reflux Disease in Children
Gastroesophageal Reflux Disease in Children
 
Gas,
Gas,Gas,
Gas,
 
Non-Steroidal Anti-inflammatory Drugs ( NSAIDs) PART I PROF SATYA 2019
Non-Steroidal Anti-inflammatory Drugs ( NSAIDs) PART I PROF SATYA  2019Non-Steroidal Anti-inflammatory Drugs ( NSAIDs) PART I PROF SATYA  2019
Non-Steroidal Anti-inflammatory Drugs ( NSAIDs) PART I PROF SATYA 2019
 
GI pharmacology
GI pharmacologyGI pharmacology
GI pharmacology
 
Non steroidal anti inflammatory drugs
Non steroidal anti inflammatory drugsNon steroidal anti inflammatory drugs
Non steroidal anti inflammatory drugs
 
Gastroesophageal reflux diseases (GERD)
Gastroesophageal reflux diseases (GERD) Gastroesophageal reflux diseases (GERD)
Gastroesophageal reflux diseases (GERD)
 
Drugs for Diarrhea and IBS.pptx
Drugs for Diarrhea and IBS.pptxDrugs for Diarrhea and IBS.pptx
Drugs for Diarrhea and IBS.pptx
 
Nephrotic syndrome
Nephrotic  syndromeNephrotic  syndrome
Nephrotic syndrome
 
Pharma4
Pharma4Pharma4
Pharma4
 
Drugs for diarrhoea & constipation
Drugs for diarrhoea & constipationDrugs for diarrhoea & constipation
Drugs for diarrhoea & constipation
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
 

Plus de Nikhil Gupta (11)

Esophagus
EsophagusEsophagus
Esophagus
 
Cholelithiasis
CholelithiasisCholelithiasis
Cholelithiasis
 
TB awareness
TB awarenessTB awareness
TB awareness
 
Life cycle of plasmodium
Life cycle of plasmodiumLife cycle of plasmodium
Life cycle of plasmodium
 
Treatment of amoebiasis & giardiasis
Treatment of amoebiasis & giardiasisTreatment of amoebiasis & giardiasis
Treatment of amoebiasis & giardiasis
 
Malabsorption syndrome
Malabsorption syndromeMalabsorption syndrome
Malabsorption syndrome
 
Lab diagnosis of diarrhoea
Lab diagnosis of diarrhoeaLab diagnosis of diarrhoea
Lab diagnosis of diarrhoea
 
Drug induced diarrhoea
Drug induced diarrhoeaDrug induced diarrhoea
Drug induced diarrhoea
 
Causesof diarrheal diseases
Causesof diarrheal diseasesCausesof diarrheal diseases
Causesof diarrheal diseases
 
Diarrhoeal control programme
Diarrhoeal control programmeDiarrhoeal control programme
Diarrhoeal control programme
 
Iron physiology
Iron physiologyIron physiology
Iron physiology
 

Ibs

  • 1. IRRITABLE BOWEL SYNDROME RAGHAV GARG MBBS 2011
  • 2. WHAT IS IRRITABLE BOWEL SYNDROME  irritable bowel syndrome can be defined ,as an idiopathic clinical entity characterized by chronic(more than 3months)abdominal pain or discomfort that occurs in association with altered bowel habits  Most are due to disorders of intestinal motility.
  • 3. SYMPTOMS These symptoms may be continuous or intermittent. Consensus definition of irritable bowel syndrome is abdominal discomfort or pain that has two of the following three features; 1.Relieved with defecation. 2.Onset associated with a change in frequency of stool 3.onset associated with a change in form of stool .
  • 4.  Other symptoms supporting the diagnosis include  abnormal stool frequency;  abnormal stool form (lumpy or hard;loose or watery);  abnormal stool passage (straining, urgency,or feeling of abdominal distention
  • 5. Signs  Examination often unremarkable  Generalized abdominal tenderness
  • 6. PATHO -PHYSIOLOGY OF IBS SUGGETSED THEORIES 1.Altered responses of general stress circuits. 2.The alternation of autonomic and neuroendocrine systems in response to visceral stimulation. 3. Serotonin release 4.low grade inflammation 5. IBS secondary to GIT infections
  • 7. 6.Increased lactobacilli, coliform in IBS 7. Genetic factors
  • 9. Constipation 1.bulk purgatives Ispaghulla and pysllium Methyl cellulose 2. Anthraquinones tegaserod Diarrhoea 1.Bulking agent 2.Antisecretory Sulfasalazine Mesalazine
  • 10. TREATMENT  FOOD INTOLERANCE  TRY EXCLUSION DIET  CONSTIPATION 1. INCREASE FIBER UPTAKE 2. BULK PURGATIVES  ISPAGHULA AND PSYLLIUM  NATURAL COLLOIDAL MUCILAGE FORMS GELATINOUS MASS BY ABSORBING WATER  3-12 g OF HUSK IS MIXED WITH WATER OR MILK  TAKEN DAILY ACT IN 1- 3 DAYS
  • 11.  METHYLCELLULOSE  SEMISYNTHETIC COLLOIDAL HYDROPHILIC DERIVATIVE OF CELLULOSE  4-6 g/day  They have non fermentable fiber better than lactulose which ferments 3 .ANTHRAQUINONES  TEGASEROD  NEW SELECTIVE 5 – HT4 RECEPTOR PARTIAL AGONIST WITH NO ACTION ON OTHER RECEPTORS  IT ENHANCES RELEASE OF Ach AND calcitonin GENE RELATED PEPTIDE WHICH PROMOTE PERISTALTIC REFLEX AND COLONIC SECRETION  elimination t1/2 of absorbed drug 11 hr
  • 12.  STIMULANT PURGATIVES (PHENOLPHTHALEIN AND BISACODYL) ARE CONTRAINDICATED
  • 13.  DIARRHOEA 1. Bulking agent as absorbants ispaghula and other bulk forming colloid are useful in both constipation and diarrhoea . They modify the consistency and frequency of stools by absorbing water
  • 14.  ANTISECRETORY SULFASALAZINE  compound of 5-aminosalicylic acid with sulfapyridine linked through azo bond.  5-ASA  it inhibits COX and LOX ,decreased PG and LT, they play minor role in the therapeutic effect.  Inhibition of cytokine, PAF, TNF and nuclear transcription factor  Migration of inflammatory cells into bowel wall is interfered and mucosal secretion is reduced
  • 15.  DOSE -3-4 g/day induces remission over a few weeks but relapses are common after stoppage  Maintenance therapy with 1.5-2 g/day postpone relapse  Adverse effects  Rashes ,fever, joint pain, hemolysis
  • 16.  MESALAZINE  formulated as delayed release preparation by coating of 5-ASA with acrylic polymer  This helps in effective delivery of the drug  DOSE - 2.4 gm prevents relapses  adverse effects are less than sulfasalazine
  • 17.  OTHER FORMS – 5 ASA enemas  Olsalazine  Balsalazine  Other drugs helpful  Corticosteroids  Immunosuppressants  Antispasmodic  in colic and bloating
  • 18. Antimotility drug  (opoid drugs  codiene , diphenoxylate , loperamide )  Contraindicated as they increase the intraluminal pressure